Stericycle, Inc. (NASDAQ:SRCL) Director Mark C. Miller sold 19,753 shares of the stock in a transaction on Monday, December 4th. The shares were sold at an average price of $67.43, for a total value of $1,331,944.79. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website.
Shares of Stericycle, Inc. (NASDAQ:SRCL) traded down $0.86 during trading on Wednesday, reaching $66.50. The company had a trading volume of 1,249,600 shares, compared to its average volume of 823,467. The firm has a market cap of $5,750.72, a P/E ratio of 15.52, a PEG ratio of 1.64 and a beta of 0.16. Stericycle, Inc. has a twelve month low of $61.25 and a twelve month high of $88.00. The company has a debt-to-equity ratio of 0.93, a current ratio of 0.82 and a quick ratio of 0.82.
Stericycle (NASDAQ:SRCL) last released its quarterly earnings results on Wednesday, November 8th. The business services provider reported $1.10 earnings per share (EPS) for the quarter, missing the Thomson Reuters’ consensus estimate of $1.14 by ($0.04). Stericycle had a negative net margin of 0.79% and a positive return on equity of 13.93%. The firm had revenue of $883.00 million during the quarter, compared to analyst estimates of $896.81 million. During the same period in the prior year, the business earned $1.24 EPS. The business’s revenue for the quarter was down .8% compared to the same quarter last year. equities research analysts predict that Stericycle, Inc. will post 4.49 EPS for the current fiscal year.
A number of brokerages have commented on SRCL. BidaskClub upgraded Stericycle from a “strong sell” rating to a “sell” rating in a research report on Saturday. Jefferies Group set a $108.00 price objective on Stericycle and gave the company a “buy” rating in a research report on Friday, August 11th. Barclays reiterated an “overweight” rating and issued a $100.00 price objective on shares of Stericycle in a research report on Wednesday, August 9th. Barrington Research decreased their price objective on Stericycle from $87.00 to $75.00 and set an “outperform” rating on the stock in a research report on Friday, November 10th. Finally, BMO Capital Markets decreased their price objective on Stericycle from $74.00 to $62.00 and set a “market perform” rating on the stock in a research report on Friday, November 10th. Four research analysts have rated the stock with a sell rating, three have assigned a hold rating and six have issued a buy rating to the company’s stock. Stericycle currently has a consensus rating of “Hold” and a consensus target price of $76.73.
ILLEGAL ACTIVITY WARNING: This news story was first reported by StockNewsTimes and is owned by of StockNewsTimes. If you are reading this news story on another website, it was stolen and reposted in violation of international trademark & copyright laws. The original version of this news story can be read at https://stocknewstimes.com/2017/12/06/stericycle-inc-srcl-director-mark-c-miller-sells-19753-shares-of-stock.html.
Stericycle, Inc is a business-to-business services provider. The Company focuses on regulated and compliance solutions for healthcare, retail, and commercial businesses. The Company’s segments include Domestic and Canada Regulated Waste and Compliance Services (RCS), Domestic Communication and Related Services (CRS), International RCS and All other.
Receive News & Ratings for Stericycle Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Stericycle Inc. and related companies with MarketBeat.com's FREE daily email newsletter.